Molecular characterization of breast cancer cell response to metabolic drugs.

about

Molecular characterization of breast cancer cell response to metabolic drugs.

Item

http://www.wikidata.org/entity/Q52689272

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Molecular characterization of breast cancer cell response to metabolic drugs.

@en

Molecular characterization of breast cancer cell response to metabolic drugs.

@nl

type

Item

label

Molecular characterization of breast cancer cell response to metabolic drugs.

@en

Molecular characterization of breast cancer cell response to metabolic drugs.

@nl

prefLabel

Molecular characterization of breast cancer cell response to metabolic drugs.

@en

Molecular characterization of breast cancer cell response to metabolic drugs.

@nl

P1476

Molecular characterization of breast cancer cell response to metabolic drugs.

@en

P2093

Alberto M Borobia

http://www.w3.org/2001/XMLSchema#string

Andrea Zapater-Moros

http://www.w3.org/2001/XMLSchema#string

Angelo Gámez-Pozo

http://www.w3.org/2001/XMLSchema#string

Enrique Espinosa

http://www.w3.org/2001/XMLSchema#string

Guillermo Prado-Vázquez

http://www.w3.org/2001/XMLSchema#string

Hilario Navarro

http://www.w3.org/2001/XMLSchema#string

Irene Dapía

http://www.w3.org/2001/XMLSchema#string

Jaime Feliú

http://www.w3.org/2001/XMLSchema#string

Jorge M Arevalillo

http://www.w3.org/2001/XMLSchema#string

Mariana Díaz-Almirón

http://www.w3.org/2001/XMLSchema#string

P2860

Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited

Role of AMP-activated protein kinase in mechanism of metformin action

Hallmarks of Cancer: The Next Generation

mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E

Ribosomal protein S27L is a direct p53 target that regulates apoptosis

SIRT5 desuccinylates and activates SOD1 to eliminate ROS

Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine

Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor-positive advanced breast cancer

The dual role of iNOS in cancer

Cancer statistics, 2015

P304

9645-9660

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24047

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lucia Trilla Fuertes

Paolo Nanni

Juan Ángel Fresno Vara

Pedro Arias

P577

2018-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29515760

http://www.w3.org/2001/XMLSchema#string

P932

5839391

http://www.w3.org/2001/XMLSchema#string